Kim Si Hyun, Han Jang Hee, Jeong Seung-Hwan, Yuk Hyeong Dong, Jeong Chang Wook, Kwak Cheol, Kim Hyeon Hoe, Kim Sang Youn, Kim Taek Min, Cho Jeong Yeon, Ku Ja Hyeon
Department of Urology, Seoul National University Hospital, Seoul, Korea.
Department of Urology, Seoul National University College of Medicine, Seoul, Korea.
Transl Androl Urol. 2023 Feb 28;12(2):168-175. doi: 10.21037/tau-22-704. Epub 2023 Feb 3.
Previous studies using the Vesical Imaging Reporting and Data System (VI-RADS) to predict muscle-invasive bladder cancer (MIBC) had some limitations. Most studies were performed with transurethral resection of bladder tumor (TUR-BT) specimens with few samples. This study was conducted to address these shortcomings and confirm the accuracy of VI-RADS for bladder cancer.
This study used data from the Seoul National University Prospectively Enrolled Registry for Urothelial Cancer-Radical Cystectomy (SUPER-UC-Cx). Patients who underwent multiparametric magnetic resonance imaging (mp-MRI) before radical cystectomy (RC) were included in this study between March 2020 and March 2022. All images were reported by radiologists and reviewed by two urologists. The patient characteristics and clinical information were blinded during the review. The performance of qualitative and quantitative variables in predicting muscle layer invasion or perivesical fat infiltration was verified by receiver operating characteristic (ROC) curve analysis.
Of 208 patients, 182 (87.5%) underwent mp-MRI before RC. Twenty-three patients with non-urothelial carcinoma, inappropriate MRI scans, and bladder filling were excluded. Cut-off for muscle invasion, VI-RADS score of 4 had the highest area under the curve (AUC) (sensitivity 0.84; specificity 0.93; accuracy 0.90; positive predictive value (PPV) 0.84; negative predictive value (NPV) 0.93, and AUC 0.88). Cut-off for perivesical fat invasion and VI-RADS score of 5 had the highest AUC (sensitivity, 0.78; specificity, 0.99; accuracy, 0.95; PPV, 0.96; NPV, 0.95; and AUC, 0.89).
VI-RADS is a good predictor of bladder cancer staging before RC and is especially helpful in predicting muscle invasion and perivesical fat infiltration.
既往使用膀胱影像报告和数据系统(VI-RADS)预测肌层浸润性膀胱癌(MIBC)的研究存在一些局限性。大多数研究是对经尿道膀胱肿瘤切除术(TUR-BT)标本进行的,样本数量较少。本研究旨在解决这些不足,并证实VI-RADS对膀胱癌的诊断准确性。
本研究使用了首尔国立大学前瞻性登记的尿路上皮癌根治性膀胱切除术(SUPER-UC-Cx)的数据。2020年3月至2022年3月期间,对在根治性膀胱切除术(RC)前接受多参数磁共振成像(mp-MRI)检查的患者进行了研究。所有图像均由放射科医生报告,并由两名泌尿外科医生进行审核。审核过程中对患者特征和临床信息进行了盲法处理。通过受试者操作特征(ROC)曲线分析验证了定性和定量变量在预测肌层浸润或膀胱周围脂肪浸润方面的性能。
208例患者中,182例(87.5%)在RC前接受了mp-MRI检查。排除23例非尿路上皮癌、MRI扫描不适当及膀胱充盈不佳的患者。对于肌层浸润的诊断标准,VI-RADS评分4时曲线下面积(AUC)最高(敏感性0.84;特异性0.93;准确性0.90;阳性预测值(PPV)0.84;阴性预测值(NPV)0.93,AUC 0.88)。对于膀胱周围脂肪浸润的诊断标准,VI-RADS评分5时AUC最高(敏感性0.78;特异性0.99;准确性0.95;PPV 0.96;NPV 0.95,AUC 0.89)。
VI-RADS是RC前膀胱癌分期的良好预测指标,尤其有助于预测肌层浸润和膀胱周围脂肪浸润。